nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—multiple sclerosis—Amitriptyline—migraine	0.375	0.608	CpDpCtD
Tizanidine—multiple sclerosis—Gabapentin—migraine	0.242	0.392	CpDpCtD
Tizanidine—ADRA2A—Amitriptyline—migraine	0.0731	0.391	CbGbCtD
Tizanidine—CYP1A2—Propranolol—migraine	0.0341	0.182	CbGbCtD
Tizanidine—CYP1A2—Amitriptyline—migraine	0.0295	0.158	CbGbCtD
Tizanidine—CYP1A2—Valproic Acid—migraine	0.0269	0.144	CbGbCtD
Tizanidine—CYP1A2—Verapamil—migraine	0.0234	0.125	CbGbCtD
Tizanidine—ADRA2C—Amine ligand-binding receptors—HTR2A—migraine	0.000297	0.00691	CbGpPWpGaD
Tizanidine—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000296	0.0069	CbGpPWpGaD
Tizanidine—ADRA2A—Monoamine GPCRs—HTR2A—migraine	0.000287	0.00668	CbGpPWpGaD
Tizanidine—ADRA2A—Amine ligand-binding receptors—HTR2A—migraine	0.000241	0.00562	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—HTR1D—migraine	0.000228	0.0053	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—HTR1D—migraine	0.000213	0.00495	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000211	0.00492	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000197	0.00459	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000196	0.00457	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—RAMP1—migraine	0.00019	0.00442	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CALCRL—migraine	0.00019	0.00442	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000184	0.00427	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000181	0.00421	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—RAMP1—migraine	0.000177	0.00413	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CALCRL—migraine	0.000177	0.00413	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—HTR1D—migraine	0.000173	0.00402	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000169	0.00394	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000168	0.00392	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00016	0.00373	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000157	0.00366	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000149	0.00347	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—RAMP1—migraine	0.000144	0.00335	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CALCRL—migraine	0.000144	0.00335	CbGpPWpGaD
Tizanidine—Anaemia—Valproic Acid—migraine	0.000141	0.00092	CcSEcCtD
Tizanidine—Immune system disorder—Timolol—migraine	0.000141	0.00092	CcSEcCtD
Tizanidine—Hypersensitivity—Propranolol—migraine	0.00014	0.000918	CcSEcCtD
Tizanidine—Mediastinal disorder—Timolol—migraine	0.00014	0.000918	CcSEcCtD
Tizanidine—Agitation—Valproic Acid—migraine	0.00014	0.000915	CcSEcCtD
Tizanidine—Urticaria—Verapamil—migraine	0.000139	0.000911	CcSEcCtD
Tizanidine—Arrhythmia—Timolol—migraine	0.000139	0.00091	CcSEcCtD
Tizanidine—Nausea—Amitriptyline—migraine	0.000139	0.000909	CcSEcCtD
Tizanidine—ADRA2B—G alpha (i) signalling events—HTR1B—migraine	0.000138	0.00321	CbGpPWpGaD
Tizanidine—Weight decreased—Topiramate—migraine	0.000138	0.000902	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR1D—migraine	0.000138	0.00321	CbGpPWpGaD
Tizanidine—Alopecia—Timolol—migraine	0.000138	0.0009	CcSEcCtD
Tizanidine—Hyperglycaemia—Topiramate—migraine	0.000138	0.000899	CcSEcCtD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000137	0.0032	CbGpPWpGaD
Tizanidine—Malaise—Valproic Acid—migraine	0.000137	0.000898	CcSEcCtD
Tizanidine—Erythema multiforme—Gabapentin—migraine	0.000137	0.000897	CcSEcCtD
Tizanidine—Vertigo—Valproic Acid—migraine	0.000137	0.000895	CcSEcCtD
Tizanidine—Asthenia—Propranolol—migraine	0.000137	0.000894	CcSEcCtD
Tizanidine—Pneumonia—Topiramate—migraine	0.000137	0.000894	CcSEcCtD
Tizanidine—Mental disorder—Timolol—migraine	0.000136	0.000892	CcSEcCtD
Tizanidine—Leukopenia—Valproic Acid—migraine	0.000136	0.000891	CcSEcCtD
Tizanidine—Depression—Topiramate—migraine	0.000136	0.000886	CcSEcCtD
Tizanidine—Tinnitus—Gabapentin—migraine	0.000135	0.000884	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Topiramate—migraine	0.000135	0.000881	CcSEcCtD
Tizanidine—Cardiac disorder—Gabapentin—migraine	0.000135	0.00088	CcSEcCtD
Tizanidine—Renal failure—Topiramate—migraine	0.000134	0.000874	CcSEcCtD
Tizanidine—Neuropathy peripheral—Topiramate—migraine	0.000133	0.000871	CcSEcCtD
Tizanidine—Tension—Timolol—migraine	0.000133	0.00087	CcSEcCtD
Tizanidine—ADRA2B—G alpha (i) signalling events—HTR1A—migraine	0.000133	0.00309	CbGpPWpGaD
Tizanidine—Conjunctivitis—Topiramate—migraine	0.000132	0.000864	CcSEcCtD
Tizanidine—Nervousness—Timolol—migraine	0.000132	0.000861	CcSEcCtD
Tizanidine—Hypertension—Valproic Acid—migraine	0.000131	0.00086	CcSEcCtD
Tizanidine—Immune system disorder—Gabapentin—migraine	0.000131	0.000856	CcSEcCtD
Tizanidine—Mediastinal disorder—Gabapentin—migraine	0.000131	0.000855	CcSEcCtD
Tizanidine—Diarrhoea—Propranolol—migraine	0.00013	0.000852	CcSEcCtD
Tizanidine—Arthralgia—Valproic Acid—migraine	0.00013	0.000848	CcSEcCtD
Tizanidine—Haematuria—Topiramate—migraine	0.00013	0.000847	CcSEcCtD
Tizanidine—Anxiety—Valproic Acid—migraine	0.000129	0.000845	CcSEcCtD
Tizanidine—Hypersensitivity—Verapamil—migraine	0.000129	0.000844	CcSEcCtD
Tizanidine—ADRA2C—G alpha (i) signalling events—HTR1B—migraine	0.000129	0.003	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—HTR1D—migraine	0.000129	0.003	CbGpPWpGaD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000129	0.000842	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR2B—migraine	0.000128	0.00298	CbGpPWpGaD
Tizanidine—Alopecia—Gabapentin—migraine	0.000128	0.000838	CcSEcCtD
Tizanidine—Discomfort—Valproic Acid—migraine	0.000128	0.000838	CcSEcCtD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000128	0.00298	CbGpPWpGaD
Tizanidine—Vision blurred—Timolol—migraine	0.000128	0.000835	CcSEcCtD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000128	0.00297	CbGpPWpGaD
Tizanidine—Sinusitis—Topiramate—migraine	0.000128	0.000834	CcSEcCtD
Tizanidine—Mental disorder—Gabapentin—migraine	0.000127	0.000831	CcSEcCtD
Tizanidine—Agranulocytosis—Topiramate—migraine	0.000127	0.000829	CcSEcCtD
Tizanidine—Dry mouth—Valproic Acid—migraine	0.000127	0.000829	CcSEcCtD
Tizanidine—Dizziness—Propranolol—migraine	0.000126	0.000824	CcSEcCtD
Tizanidine—Asthenia—Verapamil—migraine	0.000126	0.000822	CcSEcCtD
Tizanidine—Confusional state—Valproic Acid—migraine	0.000125	0.000819	CcSEcCtD
Tizanidine—Flatulence—Gabapentin—migraine	0.000124	0.000813	CcSEcCtD
Tizanidine—Anaphylactic shock—Valproic Acid—migraine	0.000124	0.000813	CcSEcCtD
Tizanidine—Oedema—Valproic Acid—migraine	0.000124	0.000813	CcSEcCtD
Tizanidine—Bradycardia—Topiramate—migraine	0.000124	0.000812	CcSEcCtD
Tizanidine—ADRA2C—G alpha (i) signalling events—HTR1A—migraine	0.000124	0.00289	CbGpPWpGaD
Tizanidine—Pruritus—Verapamil—migraine	0.000124	0.000811	CcSEcCtD
Tizanidine—Tension—Gabapentin—migraine	0.000124	0.00081	CcSEcCtD
Tizanidine—Infection—Valproic Acid—migraine	0.000123	0.000807	CcSEcCtD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000123	0.00287	CbGpPWpGaD
Tizanidine—Haemoglobin—Topiramate—migraine	0.000123	0.000802	CcSEcCtD
Tizanidine—Nervousness—Gabapentin—migraine	0.000123	0.000802	CcSEcCtD
Tizanidine—Rhinitis—Topiramate—migraine	0.000122	0.0008	CcSEcCtD
Tizanidine—Back pain—Gabapentin—migraine	0.000122	0.000798	CcSEcCtD
Tizanidine—Haemorrhage—Topiramate—migraine	0.000122	0.000798	CcSEcCtD
Tizanidine—Hepatitis—Topiramate—migraine	0.000122	0.000798	CcSEcCtD
Tizanidine—Nervous system disorder—Valproic Acid—migraine	0.000122	0.000797	CcSEcCtD
Tizanidine—Vertigo—Timolol—migraine	0.000122	0.000796	CcSEcCtD
Tizanidine—Thrombocytopenia—Valproic Acid—migraine	0.000122	0.000796	CcSEcCtD
Tizanidine—Syncope—Timolol—migraine	0.000122	0.000795	CcSEcCtD
Tizanidine—Hallucination—Topiramate—migraine	0.000121	0.000794	CcSEcCtD
Tizanidine—Muscle spasms—Gabapentin—migraine	0.000121	0.000794	CcSEcCtD
Tizanidine—Tachycardia—Valproic Acid—migraine	0.000121	0.000793	CcSEcCtD
Tizanidine—Vomiting—Propranolol—migraine	0.000121	0.000792	CcSEcCtD
Tizanidine—Pharyngitis—Topiramate—migraine	0.000121	0.000792	CcSEcCtD
Tizanidine—Skin disorder—Valproic Acid—migraine	0.000121	0.000789	CcSEcCtD
Tizanidine—Urinary tract disorder—Topiramate—migraine	0.00012	0.000788	CcSEcCtD
Tizanidine—Hyperhidrosis—Valproic Acid—migraine	0.00012	0.000786	CcSEcCtD
Tizanidine—Rash—Propranolol—migraine	0.00012	0.000786	CcSEcCtD
Tizanidine—Dermatitis—Propranolol—migraine	0.00012	0.000785	CcSEcCtD
Tizanidine—Diarrhoea—Verapamil—migraine	0.00012	0.000784	CcSEcCtD
Tizanidine—Connective tissue disorder—Topiramate—migraine	0.00012	0.000784	CcSEcCtD
Tizanidine—ADRA2C—GPCR ligand binding—HTR2B—migraine	0.00012	0.00279	CbGpPWpGaD
Tizanidine—Urethral disorder—Topiramate—migraine	0.00012	0.000782	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00012	0.00278	CbGpPWpGaD
Tizanidine—Loss of consciousness—Timolol—migraine	0.000119	0.000779	CcSEcCtD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000119	0.00277	CbGpPWpGaD
Tizanidine—Vision blurred—Gabapentin—migraine	0.000119	0.000778	CcSEcCtD
Tizanidine—Tremor—Gabapentin—migraine	0.000118	0.000773	CcSEcCtD
Tizanidine—Ill-defined disorder—Gabapentin—migraine	0.000117	0.000766	CcSEcCtD
Tizanidine—Hypertension—Timolol—migraine	0.000117	0.000765	CcSEcCtD
Tizanidine—Anaemia—Gabapentin—migraine	0.000117	0.000763	CcSEcCtD
Tizanidine—Hypotension—Valproic Acid—migraine	0.000116	0.000759	CcSEcCtD
Tizanidine—Agitation—Gabapentin—migraine	0.000116	0.000759	CcSEcCtD
Tizanidine—Dizziness—Verapamil—migraine	0.000116	0.000758	CcSEcCtD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000116	0.00269	CbGpPWpGaD
Tizanidine—Arthralgia—Timolol—migraine	0.000115	0.000755	CcSEcCtD
Tizanidine—Erythema multiforme—Topiramate—migraine	0.000115	0.000754	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000115	0.00268	CbGpPWpGaD
Tizanidine—Anxiety—Timolol—migraine	0.000115	0.000752	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000115	0.000749	CcSEcCtD
Tizanidine—Discomfort—Timolol—migraine	0.000114	0.000746	CcSEcCtD
Tizanidine—Malaise—Gabapentin—migraine	0.000114	0.000744	CcSEcCtD
Tizanidine—Tinnitus—Topiramate—migraine	0.000114	0.000744	CcSEcCtD
Tizanidine—Vertigo—Gabapentin—migraine	0.000113	0.000742	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000113	0.00074	CcSEcCtD
Tizanidine—Cardiac disorder—Topiramate—migraine	0.000113	0.00074	CcSEcCtD
Tizanidine—Syncope—Gabapentin—migraine	0.000113	0.00074	CcSEcCtD
Tizanidine—Nausea—Propranolol—migraine	0.000113	0.00074	CcSEcCtD
Tizanidine—Leukopenia—Gabapentin—migraine	0.000113	0.000739	CcSEcCtD
Tizanidine—Dry mouth—Timolol—migraine	0.000113	0.000738	CcSEcCtD
Tizanidine—Paraesthesia—Valproic Acid—migraine	0.000112	0.00073	CcSEcCtD
Tizanidine—Confusional state—Timolol—migraine	0.000112	0.000729	CcSEcCtD
Tizanidine—Vomiting—Verapamil—migraine	0.000111	0.000729	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000111	0.00259	CbGpPWpGaD
Tizanidine—Loss of consciousness—Gabapentin—migraine	0.000111	0.000726	CcSEcCtD
Tizanidine—Dyspnoea—Valproic Acid—migraine	0.000111	0.000725	CcSEcCtD
Tizanidine—Angiopathy—Topiramate—migraine	0.000111	0.000724	CcSEcCtD
Tizanidine—Anaphylactic shock—Timolol—migraine	0.000111	0.000723	CcSEcCtD
Tizanidine—Oedema—Timolol—migraine	0.000111	0.000723	CcSEcCtD
Tizanidine—Rash—Verapamil—migraine	0.000111	0.000723	CcSEcCtD
Tizanidine—Somnolence—Valproic Acid—migraine	0.00011	0.000722	CcSEcCtD
Tizanidine—Dermatitis—Verapamil—migraine	0.00011	0.000722	CcSEcCtD
Tizanidine—Immune system disorder—Topiramate—migraine	0.00011	0.000721	CcSEcCtD
Tizanidine—Mediastinal disorder—Topiramate—migraine	0.00011	0.000719	CcSEcCtD
Tizanidine—Infection—Timolol—migraine	0.00011	0.000719	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00011	0.00255	CbGpPWpGaD
Tizanidine—Dyspepsia—Valproic Acid—migraine	0.000109	0.000715	CcSEcCtD
Tizanidine—Convulsion—Gabapentin—migraine	0.000109	0.000715	CcSEcCtD
Tizanidine—Hypertension—Gabapentin—migraine	0.000109	0.000713	CcSEcCtD
Tizanidine—Shock—Timolol—migraine	0.000109	0.000712	CcSEcCtD
Tizanidine—Nervous system disorder—Timolol—migraine	0.000109	0.000709	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000108	0.00252	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000108	0.00251	CbGpPWpGaD
Tizanidine—Alopecia—Topiramate—migraine	0.000108	0.000705	CcSEcCtD
Tizanidine—Arthralgia—Gabapentin—migraine	0.000107	0.000703	CcSEcCtD
Tizanidine—Skin disorder—Timolol—migraine	0.000107	0.000703	CcSEcCtD
Tizanidine—ADRA2B—GPCR downstream signaling—RAMP1—migraine	0.000107	0.0025	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CALCRL—migraine	0.000107	0.0025	CbGpPWpGaD
Tizanidine—Fatigue—Valproic Acid—migraine	0.000107	0.000701	CcSEcCtD
Tizanidine—Anxiety—Gabapentin—migraine	0.000107	0.0007	CcSEcCtD
Tizanidine—Hyperhidrosis—Timolol—migraine	0.000107	0.000699	CcSEcCtD
Tizanidine—Mental disorder—Topiramate—migraine	0.000107	0.000699	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000107	0.000698	CcSEcCtD
Tizanidine—Constipation—Valproic Acid—migraine	0.000106	0.000695	CcSEcCtD
Tizanidine—Discomfort—Gabapentin—migraine	0.000106	0.000694	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000106	0.00246	CbGpPWpGaD
Tizanidine—Dry mouth—Gabapentin—migraine	0.000105	0.000687	CcSEcCtD
Tizanidine—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	0.000105	0.00244	CbGpPWpGaD
Tizanidine—Flatulence—Topiramate—migraine	0.000105	0.000684	CcSEcCtD
Tizanidine—ADRA2A—GPCR ligand binding—HTR1D—migraine	0.000105	0.00243	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000104	0.00243	CbGpPWpGaD
Tizanidine—Tension—Topiramate—migraine	0.000104	0.000681	CcSEcCtD
Tizanidine—Nausea—Verapamil—migraine	0.000104	0.000681	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000104	0.00242	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000104	0.00242	CbGpPWpGaD
Tizanidine—Confusional state—Gabapentin—migraine	0.000104	0.000679	CcSEcCtD
Tizanidine—Hypotension—Timolol—migraine	0.000103	0.000676	CcSEcCtD
Tizanidine—Nervousness—Topiramate—migraine	0.000103	0.000674	CcSEcCtD
Tizanidine—Anaphylactic shock—Gabapentin—migraine	0.000103	0.000674	CcSEcCtD
Tizanidine—Oedema—Gabapentin—migraine	0.000103	0.000674	CcSEcCtD
Tizanidine—Back pain—Topiramate—migraine	0.000103	0.000672	CcSEcCtD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000102	0.00238	CbGpPWpGaD
Tizanidine—Feeling abnormal—Valproic Acid—migraine	0.000102	0.00067	CcSEcCtD
Tizanidine—Infection—Gabapentin—migraine	0.000102	0.000669	CcSEcCtD
Tizanidine—Muscle spasms—Topiramate—migraine	0.000102	0.000668	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000102	0.00237	CbGpPWpGaD
Tizanidine—Gastrointestinal pain—Valproic Acid—migraine	0.000102	0.000665	CcSEcCtD
Tizanidine—Shock—Gabapentin—migraine	0.000101	0.000663	CcSEcCtD
Tizanidine—Nervous system disorder—Gabapentin—migraine	0.000101	0.000661	CcSEcCtD
Tizanidine—Thrombocytopenia—Gabapentin—migraine	0.000101	0.00066	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Timolol—migraine	0.000101	0.000659	CcSEcCtD
Tizanidine—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	0.000101	0.00235	CbGpPWpGaD
Tizanidine—Tachycardia—Gabapentin—migraine	0.000101	0.000657	CcSEcCtD
Tizanidine—ADRA2C—GPCR downstream signaling—RAMP1—migraine	0.0001	0.00233	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CALCRL—migraine	0.0001	0.00233	CbGpPWpGaD
Tizanidine—Vision blurred—Topiramate—migraine	0.0001	0.000654	CcSEcCtD
Tizanidine—Skin disorder—Gabapentin—migraine	0.0001	0.000654	CcSEcCtD
Tizanidine—Hyperhidrosis—Gabapentin—migraine	9.96e-05	0.000651	CcSEcCtD
Tizanidine—Tremor—Topiramate—migraine	9.95e-05	0.000651	CcSEcCtD
Tizanidine—Paraesthesia—Timolol—migraine	9.94e-05	0.00065	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	9.92e-05	0.00231	CbGpPWpGaD
Tizanidine—Urticaria—Valproic Acid—migraine	9.87e-05	0.000646	CcSEcCtD
Tizanidine—Dyspnoea—Timolol—migraine	9.86e-05	0.000645	CcSEcCtD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.86e-05	0.0023	CbGpPWpGaD
Tizanidine—Ill-defined disorder—Topiramate—migraine	9.86e-05	0.000644	CcSEcCtD
Tizanidine—Somnolence—Timolol—migraine	9.84e-05	0.000643	CcSEcCtD
Tizanidine—Body temperature increased—Valproic Acid—migraine	9.83e-05	0.000642	CcSEcCtD
Tizanidine—Abdominal pain—Valproic Acid—migraine	9.83e-05	0.000642	CcSEcCtD
Tizanidine—Anaemia—Topiramate—migraine	9.82e-05	0.000642	CcSEcCtD
Tizanidine—Agitation—Topiramate—migraine	9.76e-05	0.000638	CcSEcCtD
Tizanidine—Dyspepsia—Timolol—migraine	9.74e-05	0.000637	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	9.74e-05	0.00227	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RAMP1—migraine	9.74e-05	0.00227	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CALCRL—migraine	9.74e-05	0.00227	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR2B—migraine	9.73e-05	0.00226	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.71e-05	0.00226	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	9.71e-05	0.00226	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	9.71e-05	0.00226	CbGpPWpGaD
Tizanidine—Hypotension—Gabapentin—migraine	9.63e-05	0.00063	CcSEcCtD
Tizanidine—Malaise—Topiramate—migraine	9.58e-05	0.000626	CcSEcCtD
Tizanidine—Vertigo—Topiramate—migraine	9.54e-05	0.000624	CcSEcCtD
Tizanidine—Fatigue—Timolol—migraine	9.54e-05	0.000624	CcSEcCtD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	9.53e-05	0.00222	CbGpPWpGaD
Tizanidine—Syncope—Topiramate—migraine	9.53e-05	0.000623	CcSEcCtD
Tizanidine—Leukopenia—Topiramate—migraine	9.51e-05	0.000622	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Gabapentin—migraine	9.39e-05	0.000614	CcSEcCtD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.35e-05	0.00218	CbGpPWpGaD
Tizanidine—Loss of consciousness—Topiramate—migraine	9.34e-05	0.00061	CcSEcCtD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	9.27e-05	0.00216	CbGpPWpGaD
Tizanidine—Paraesthesia—Gabapentin—migraine	9.25e-05	0.000605	CcSEcCtD
Tizanidine—Convulsion—Topiramate—migraine	9.2e-05	0.000602	CcSEcCtD
Tizanidine—Dyspnoea—Gabapentin—migraine	9.19e-05	0.000601	CcSEcCtD
Tizanidine—Hypertension—Topiramate—migraine	9.17e-05	0.0006	CcSEcCtD
Tizanidine—Somnolence—Gabapentin—migraine	9.16e-05	0.000599	CcSEcCtD
Tizanidine—Hypersensitivity—Valproic Acid—migraine	9.16e-05	0.000599	CcSEcCtD
Tizanidine—Feeling abnormal—Timolol—migraine	9.12e-05	0.000596	CcSEcCtD
Tizanidine—ADRA2C—Signaling by GPCR—CALCRL—migraine	9.1e-05	0.00212	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RAMP1—migraine	9.1e-05	0.00212	CbGpPWpGaD
Tizanidine—Dyspepsia—Gabapentin—migraine	9.07e-05	0.000593	CcSEcCtD
Tizanidine—Gastrointestinal pain—Timolol—migraine	9.05e-05	0.000592	CcSEcCtD
Tizanidine—Arthralgia—Topiramate—migraine	9.04e-05	0.000591	CcSEcCtD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	9.03e-05	0.0021	CbGpPWpGaD
Tizanidine—Anxiety—Topiramate—migraine	9.01e-05	0.000589	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	8.98e-05	0.000587	CcSEcCtD
Tizanidine—Discomfort—Topiramate—migraine	8.93e-05	0.000584	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	8.93e-05	0.00208	CbGpPWpGaD
Tizanidine—Asthenia—Valproic Acid—migraine	8.92e-05	0.000583	CcSEcCtD
Tizanidine—Fatigue—Gabapentin—migraine	8.88e-05	0.000581	CcSEcCtD
Tizanidine—Dry mouth—Topiramate—migraine	8.84e-05	0.000578	CcSEcCtD
Tizanidine—Constipation—Gabapentin—migraine	8.81e-05	0.000576	CcSEcCtD
Tizanidine—Pruritus—Valproic Acid—migraine	8.79e-05	0.000575	CcSEcCtD
Tizanidine—Urticaria—Timolol—migraine	8.79e-05	0.000575	CcSEcCtD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.79e-05	0.00204	CbGpPWpGaD
Tizanidine—Abdominal pain—Timolol—migraine	8.75e-05	0.000572	CcSEcCtD
Tizanidine—Body temperature increased—Timolol—migraine	8.75e-05	0.000572	CcSEcCtD
Tizanidine—Confusional state—Topiramate—migraine	8.74e-05	0.000571	CcSEcCtD
Tizanidine—Oedema—Topiramate—migraine	8.67e-05	0.000567	CcSEcCtD
Tizanidine—Infection—Topiramate—migraine	8.61e-05	0.000563	CcSEcCtD
Tizanidine—Shock—Topiramate—migraine	8.53e-05	0.000558	CcSEcCtD
Tizanidine—Diarrhoea—Valproic Acid—migraine	8.5e-05	0.000556	CcSEcCtD
Tizanidine—Nervous system disorder—Topiramate—migraine	8.5e-05	0.000556	CcSEcCtD
Tizanidine—Feeling abnormal—Gabapentin—migraine	8.49e-05	0.000555	CcSEcCtD
Tizanidine—Thrombocytopenia—Topiramate—migraine	8.49e-05	0.000555	CcSEcCtD
Tizanidine—Tachycardia—Topiramate—migraine	8.46e-05	0.000553	CcSEcCtD
Tizanidine—Gastrointestinal pain—Gabapentin—migraine	8.43e-05	0.000551	CcSEcCtD
Tizanidine—Skin disorder—Topiramate—migraine	8.42e-05	0.000551	CcSEcCtD
Tizanidine—Hyperhidrosis—Topiramate—migraine	8.38e-05	0.000548	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR1B—migraine	8.35e-05	0.00194	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	8.34e-05	0.00194	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.32e-05	0.00194	CbGpPWpGaD
Tizanidine—Dizziness—Valproic Acid—migraine	8.22e-05	0.000537	CcSEcCtD
Tizanidine—Urticaria—Gabapentin—migraine	8.19e-05	0.000535	CcSEcCtD
Tizanidine—Hypersensitivity—Timolol—migraine	8.15e-05	0.000533	CcSEcCtD
Tizanidine—Body temperature increased—Gabapentin—migraine	8.15e-05	0.000533	CcSEcCtD
Tizanidine—Abdominal pain—Gabapentin—migraine	8.15e-05	0.000533	CcSEcCtD
Tizanidine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	8.14e-05	0.00189	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	8.14e-05	0.00189	CbGpPWpGaD
Tizanidine—Hypotension—Topiramate—migraine	8.1e-05	0.00053	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR1A—migraine	8.04e-05	0.00187	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.01e-05	0.00186	CbGpPWpGaD
Tizanidine—Asthenia—Timolol—migraine	7.94e-05	0.000519	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—TAC1—migraine	7.92e-05	0.00184	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—NPS—migraine	7.92e-05	0.00184	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.91e-05	0.00184	CbGpPWpGaD
Tizanidine—Vomiting—Valproic Acid—migraine	7.9e-05	0.000517	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Topiramate—migraine	7.9e-05	0.000516	CcSEcCtD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.89e-05	0.00184	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.89e-05	0.00184	CbGpPWpGaD
Tizanidine—Rash—Valproic Acid—migraine	7.84e-05	0.000512	CcSEcCtD
Tizanidine—Dermatitis—Valproic Acid—migraine	7.83e-05	0.000512	CcSEcCtD
Tizanidine—Pruritus—Timolol—migraine	7.83e-05	0.000512	CcSEcCtD
Tizanidine—ADRA2C—GPCR ligand binding—HTR1B—migraine	7.8e-05	0.00182	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR1D—migraine	7.79e-05	0.00181	CbGpPWpGaD
Tizanidine—Paraesthesia—Topiramate—migraine	7.78e-05	0.000509	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR2C—migraine	7.77e-05	0.00181	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.74e-05	0.0018	CbGpPWpGaD
Tizanidine—Dyspnoea—Topiramate—migraine	7.73e-05	0.000505	CcSEcCtD
Tizanidine—Somnolence—Topiramate—migraine	7.71e-05	0.000504	CcSEcCtD
Tizanidine—Dyspepsia—Topiramate—migraine	7.63e-05	0.000499	CcSEcCtD
Tizanidine—Hypersensitivity—Gabapentin—migraine	7.59e-05	0.000496	CcSEcCtD
Tizanidine—Diarrhoea—Timolol—migraine	7.57e-05	0.000495	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—EDNRA—migraine	7.55e-05	0.00176	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.53e-05	0.00175	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—HTR1A—migraine	7.51e-05	0.00175	CbGpPWpGaD
Tizanidine—Fatigue—Topiramate—migraine	7.47e-05	0.000489	CcSEcCtD
Tizanidine—Constipation—Topiramate—migraine	7.41e-05	0.000485	CcSEcCtD
Tizanidine—ADRA2C—GPCR ligand binding—NPS—migraine	7.4e-05	0.00172	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—TAC1—migraine	7.4e-05	0.00172	CbGpPWpGaD
Tizanidine—Asthenia—Gabapentin—migraine	7.39e-05	0.000483	CcSEcCtD
Tizanidine—ADRA2A—Signaling by GPCR—RAMP1—migraine	7.39e-05	0.00172	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CALCRL—migraine	7.39e-05	0.00172	CbGpPWpGaD
Tizanidine—Nausea—Valproic Acid—migraine	7.38e-05	0.000483	CcSEcCtD
Tizanidine—Dizziness—Timolol—migraine	7.32e-05	0.000478	CcSEcCtD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.3e-05	0.0017	CbGpPWpGaD
Tizanidine—Pruritus—Gabapentin—migraine	7.29e-05	0.000477	CcSEcCtD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR1D—migraine	7.28e-05	0.00169	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CALCA—migraine	7.27e-05	0.00169	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—HTR2C—migraine	7.25e-05	0.00169	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR2B—migraine	7.24e-05	0.00169	CbGpPWpGaD
Tizanidine—Feeling abnormal—Topiramate—migraine	7.14e-05	0.000467	CcSEcCtD
Tizanidine—Gastrointestinal pain—Topiramate—migraine	7.09e-05	0.000463	CcSEcCtD
Tizanidine—ADRA2B—Signaling by GPCR—HTR1D—migraine	7.08e-05	0.00165	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—EDNRA—migraine	7.06e-05	0.00164	CbGpPWpGaD
Tizanidine—Diarrhoea—Gabapentin—migraine	7.05e-05	0.000461	CcSEcCtD
Tizanidine—Vomiting—Timolol—migraine	7.04e-05	0.00046	CcSEcCtD
Tizanidine—Rash—Timolol—migraine	6.98e-05	0.000456	CcSEcCtD
Tizanidine—Dermatitis—Timolol—migraine	6.97e-05	0.000456	CcSEcCtD
Tizanidine—Urticaria—Topiramate—migraine	6.89e-05	0.00045	CcSEcCtD
Tizanidine—Body temperature increased—Topiramate—migraine	6.85e-05	0.000448	CcSEcCtD
Tizanidine—Abdominal pain—Topiramate—migraine	6.85e-05	0.000448	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.82e-05	0.00159	CbGpPWpGaD
Tizanidine—Dizziness—Gabapentin—migraine	6.81e-05	0.000445	CcSEcCtD
Tizanidine—ADRA2B—GPCR ligand binding—HTR7—migraine	6.8e-05	0.00158	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CALCA—migraine	6.79e-05	0.00158	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.78e-05	0.00158	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR2B—migraine	6.77e-05	0.00157	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR1D—migraine	6.61e-05	0.00154	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR2B—migraine	6.58e-05	0.00153	CbGpPWpGaD
Tizanidine—Nausea—Timolol—migraine	6.57e-05	0.00043	CcSEcCtD
Tizanidine—Vomiting—Gabapentin—migraine	6.55e-05	0.000428	CcSEcCtD
Tizanidine—Rash—Gabapentin—migraine	6.5e-05	0.000425	CcSEcCtD
Tizanidine—Dermatitis—Gabapentin—migraine	6.49e-05	0.000424	CcSEcCtD
Tizanidine—Hypersensitivity—Topiramate—migraine	6.39e-05	0.000418	CcSEcCtD
Tizanidine—ADRA2C—GPCR ligand binding—HTR7—migraine	6.35e-05	0.00148	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR1B—migraine	6.34e-05	0.00148	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.26e-05	0.00146	CbGpPWpGaD
Tizanidine—Asthenia—Topiramate—migraine	6.22e-05	0.000407	CcSEcCtD
Tizanidine—ADRA2C—Signaling by GPCR—HTR2B—migraine	6.14e-05	0.00143	CbGpPWpGaD
Tizanidine—Pruritus—Topiramate—migraine	6.13e-05	0.000401	CcSEcCtD
Tizanidine—Nausea—Gabapentin—migraine	6.12e-05	0.0004	CcSEcCtD
Tizanidine—ADRA2A—GPCR ligand binding—HTR1A—migraine	6.1e-05	0.00142	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—NPS—migraine	6.01e-05	0.0014	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—TAC1—migraine	6.01e-05	0.0014	CbGpPWpGaD
Tizanidine—Diarrhoea—Topiramate—migraine	5.93e-05	0.000388	CcSEcCtD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	5.91e-05	0.00138	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR2C—migraine	5.89e-05	0.00137	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.84e-05	0.00136	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAMP1—migraine	5.75e-05	0.00134	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CALCRL—migraine	5.75e-05	0.00134	CbGpPWpGaD
Tizanidine—Dizziness—Topiramate—migraine	5.73e-05	0.000375	CcSEcCtD
Tizanidine—ADRA2A—GPCR ligand binding—EDNRA—migraine	5.73e-05	0.00133	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.54e-05	0.00129	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CALCA—migraine	5.52e-05	0.00128	CbGpPWpGaD
Tizanidine—Vomiting—Topiramate—migraine	5.51e-05	0.00036	CcSEcCtD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	5.5e-05	0.00128	CbGpPWpGaD
Tizanidine—Rash—Topiramate—migraine	5.47e-05	0.000357	CcSEcCtD
Tizanidine—Dermatitis—Topiramate—migraine	5.46e-05	0.000357	CcSEcCtD
Tizanidine—ADRA2C—Signaling Pathways—CALCRL—migraine	5.37e-05	0.00125	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAMP1—migraine	5.37e-05	0.00125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR1D—migraine	5.37e-05	0.00125	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	5.22e-05	0.00122	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	5.22e-05	0.00122	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR7—migraine	5.16e-05	0.0012	CbGpPWpGaD
Tizanidine—Nausea—Topiramate—migraine	5.15e-05	0.000337	CcSEcCtD
Tizanidine—ADRA2A—Signaling by GPCR—HTR2B—migraine	4.99e-05	0.00116	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CACNA1A—migraine	4.87e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—HTR2A—migraine	4.76e-05	0.00111	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.75e-05	0.0011	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR1B—migraine	4.72e-05	0.0011	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR1A—migraine	4.54e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—TAC1—migraine	4.48e-05	0.00104	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—NPS—migraine	4.48e-05	0.00104	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—HTR2A—migraine	4.45e-05	0.00104	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR1B—migraine	4.41e-05	0.00103	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR2C—migraine	4.39e-05	0.00102	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAMP1—migraine	4.36e-05	0.00102	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALCRL—migraine	4.36e-05	0.00102	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR1B—migraine	4.29e-05	0.000998	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—EDNRA—migraine	4.27e-05	0.000994	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR1A—migraine	4.24e-05	0.000988	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—TAC1—migraine	4.18e-05	0.000973	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—NPS—migraine	4.18e-05	0.000973	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR1D—migraine	4.18e-05	0.000973	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR1A—migraine	4.13e-05	0.00096	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CALCA—migraine	4.11e-05	0.000956	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR2C—migraine	4.1e-05	0.000954	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—TAC1—migraine	4.06e-05	0.000946	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—NPS—migraine	4.06e-05	0.000946	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR1B—migraine	4e-05	0.000932	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—EDNRA—migraine	3.99e-05	0.000928	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR2C—migraine	3.99e-05	0.000928	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CACNA1A—migraine	3.96e-05	0.000921	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR1D—migraine	3.9e-05	0.000909	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2B—migraine	3.89e-05	0.000904	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EDNRA—migraine	3.88e-05	0.000902	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR1A—migraine	3.85e-05	0.000897	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR7—migraine	3.84e-05	0.000895	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CALCA—migraine	3.84e-05	0.000893	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—TAC1—migraine	3.8e-05	0.000883	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—NPS—migraine	3.8e-05	0.000883	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CALCA—migraine	3.73e-05	0.000869	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR2C—migraine	3.72e-05	0.000866	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2B—migraine	3.63e-05	0.000845	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EDNRA—migraine	3.62e-05	0.000843	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR2A—migraine	3.61e-05	0.000841	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR7—migraine	3.59e-05	0.000836	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	3.58e-05	0.000834	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR7—migraine	3.49e-05	0.000812	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CALCA—migraine	3.49e-05	0.000811	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	3.45e-05	0.000802	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LRP1—migraine	3.42e-05	0.000796	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—TAC1—migraine	3.4e-05	0.00079	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—NPS—migraine	3.4e-05	0.00079	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	3.33e-05	0.000775	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR7—migraine	3.26e-05	0.000759	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR1B—migraine	3.25e-05	0.000757	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	3.24e-05	0.000754	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LRP1—migraine	3.2e-05	0.000744	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR1D—migraine	3.17e-05	0.000738	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR1A—migraine	3.13e-05	0.000729	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CALCA—migraine	3.12e-05	0.000726	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—TAC1—migraine	3.08e-05	0.000718	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—NPS—migraine	3.08e-05	0.000718	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR2C—migraine	3.02e-05	0.000704	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2B—migraine	2.95e-05	0.000686	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EDNRA—migraine	2.94e-05	0.000685	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR7—migraine	2.92e-05	0.000679	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CALCA—migraine	2.83e-05	0.000659	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR2A—migraine	2.69e-05	0.000627	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR7—migraine	2.65e-05	0.000616	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH4—migraine	2.62e-05	0.000611	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LRP1—migraine	2.6e-05	0.000604	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR1B—migraine	2.53e-05	0.000589	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR2A—migraine	2.51e-05	0.000585	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH4—migraine	2.45e-05	0.000571	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR2A—migraine	2.44e-05	0.000569	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR1A—migraine	2.44e-05	0.000567	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TAC1—migraine	2.4e-05	0.000559	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NPS—migraine	2.4e-05	0.000559	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PGR—migraine	2.4e-05	0.000559	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR1B—migraine	2.37e-05	0.000551	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2C—migraine	2.35e-05	0.000548	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EDNRA—migraine	2.29e-05	0.000533	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR2A—migraine	2.28e-05	0.000531	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR1A—migraine	2.28e-05	0.00053	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TAC1—migraine	2.24e-05	0.000522	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NPS—migraine	2.24e-05	0.000522	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PGR—migraine	2.24e-05	0.000522	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH3—migraine	2.23e-05	0.000519	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CALCA—migraine	2.2e-05	0.000513	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2C—migraine	2.2e-05	0.000512	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CACNA1A—migraine	2.18e-05	0.000508	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EDNRA—migraine	2.14e-05	0.000498	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH3—migraine	2.08e-05	0.000485	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR7—migraine	2.06e-05	0.00048	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CALCA—migraine	2.06e-05	0.000479	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	2.04e-05	0.000475	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH4—migraine	1.99e-05	0.000463	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR7—migraine	1.93e-05	0.000448	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR1B—migraine	1.92e-05	0.000447	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR2A—migraine	1.85e-05	0.000432	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR1A—migraine	1.85e-05	0.00043	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TAC1—migraine	1.82e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PGR—migraine	1.82e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NPS—migraine	1.82e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2C—migraine	1.79e-05	0.000416	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFBR2—migraine	1.78e-05	0.000413	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDNRA—migraine	1.74e-05	0.000404	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH3—migraine	1.69e-05	0.000394	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALCA—migraine	1.67e-05	0.000389	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFBR2—migraine	1.66e-05	0.000386	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—migraine	1.61e-05	0.000375	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR7—migraine	1.56e-05	0.000364	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2A—migraine	1.44e-05	0.000336	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2A—migraine	1.35e-05	0.000314	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFBR2—migraine	1.35e-05	0.000314	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—migraine	1.31e-05	0.000305	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—migraine	1.28e-05	0.000298	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—migraine	1.2e-05	0.000279	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2A—migraine	1.1e-05	0.000255	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—migraine	9.73e-06	0.000226	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—migraine	7.22e-06	0.000168	CbGpPWpGaD
